Introduction
Molecules underlying transduction of visual, olfactory, gustatory and touch stimuli have been identified in mammals, yet the molecular bases of many of the most basic auditory system phenomena remain unknown 3 . Functional and cDNA cloning of genes that are important for auditory function is hindered by the scarce amounts of neurosensory tissue in the inner ear. Positional cloning of genes underlying human and mouse forms of hereditary deafness circumvents these limitations and can identify molecular substrata responsible for perception and processing of sound in the auditory system 4 . Genes identified through human and mouse models of hereditary deafness have begun to define crucial molecules in the inner ear underlying its morphogenesis, specialized extracellular matrices, the development, structure and function of neurosensory hair cells, and electrochemical homeostasis. In spite of this rapid progress, genetic dissection of the auditory system is incomplete 5 . Positional cloning of hereditary hearing-loss genes continues to identify new molecules and mechanisms underlying both normal and pathologic processes in the auditory system [6] [7] [8] [9] [10] [11] .
We report here the identification of TMC1, which underlies dominant and recessive nonsyndromic hearing loss at the DFNA36 and DFNB7/B11 loci. TMC1 is one member of a new family of genes encoding transmembrane proteins of unknown function. We also describe the mouse ortholog, Tmc1, and show that it is mutated in the recessive deafness (dn) mutant. The auditory phenotype of dn mutant mice 1,2 suggests a possible role for TMC1 in mechanoelectrical transduction of sound by cochlear hair cells.
Results

Genetic map of DFNA36 and DFNB7/B11
We ascertained a large North American family, LMG128 (Fig.  1a) , segregating dominant, nonsyndromic, bilateral, symmetric, sensorineural hearing loss that begins at 5-10 years of age and rapidly progresses to profound deafness within 10-15 years (Fig.  1b) . Affected individuals had no evidence of vestibular deficits in their developmental and medical histories or upon physical examination. The hearing-loss phenotype did not segregate with microsatellite markers flanking any of the known DFNA loci, (Fig. 1c,d ,e). Haplotype analyses of chromosome 9q13-21 markers in these families showed a small region of shared linkage between D9S1822 and D9S924 ( Fig. 2) , defined by a centromeric recombination breakpoint in individuals 20 and 24 of PKSR9 (Fig. 1c) and an ancestral telomeric breakpoint in PKSR25 (Fig. 1d) . The combined critical interval of approximately 3 Mb narrowed both ends of a previously reported region for this locus 14 and is entirely contained within the 6-Mb critical interval for DFNA36 between D9S15 and D9S175 (Fig. 2) .
We evaluated positional candidate genes in the DFNA36 and DFNB7/B11 critical regions by sequence analysis of predicted exons in genomic DNA from affected individuals from the DFNA36 family and the 11 DFNB7/B11 families. We did not find mutations in the TMEM2, ZNF216, ALDH1A1 or ANXA1 genes (Fig. 2) . BLASTx, GENSCAN and FGENES analyses identified one predicted gene (with sequence similarity to the expressed-sequence tag KIAA1099) in the critical region, but no mutations were detected (data not shown).
The TMC gene family To identify additional DFNA36/B7/B11 candidate genes based upon sequence similarity to related genes elsewhere in the genome, we initiated a systematic tBLASTx analysis of segments of genomic DNA sequence in the DFNA36/B7/B11 interval. Query sequences from BAC 296H15 containing part of this interval were similar to a predicted gene (subsequently named TMC2) on chromosome 20p13. We used conserved sequences between TMC2 and the query sequence (subsequently named TMC1) on chromosome 9q13-21 to design primers for amplifying potential TMC1 transcripts from a human fetal-brain cDNA library. We sequenced a 0.8-kb amplification product and confirmed that it represented an mRNA transcript corresponding to exons 7-16 of article TMC1 (Fig. 2) . 5′ and 3′ RACE of human inner-ear cDNA produced additional cDNA fragments whose aligned sequences included a (longest) open reading frame (ORF) of 2,283 nt, predicted to encode an 87-kD protein. Alignment of the cDNA with genomic sequences showed that 24 exons probably encode the full-length mRNA, including 4 exons encoding sequence upstream of a methionine codon in exon 5 (Fig. 2 ). There are many in-frame stop codons directly upstream of this methionine codon, which is predicted to be an adequate Kozak translation initiation codon (Fig. 2) 15 . We obtained the orthologous mouse Tmc1 cDNA by RT-PCR and 5′ and 3′ RACE of mouse inner-ear cDNA. Overlapping cDNA products were aligned to identify the longest (2,274 nt) ORF of mouse Tmc1, which is also predicted to encode an 87-kD protein. The putative translation initiation codon is also preceded by an in-frame, upstream stop codon. The adjacent sequence, tcttttATGt, does not have a purine at -3 or guanine at +4, which are the two most conserved positions of the consensus translation-initiation sequence 15, 16 . The next in-frame methionine codon is at M107, which corresponds to M113 in human TMC1 and has the conserved purine at -3 and guanine at +4. The genomic structure of Tmc1 was determined by aligning cDNA sequence with mouse genomic DNA sequence. The Tmc1 ORF is encoded by 20 exons, with one upstream exon encoding the 5′ untranslated region (UTR; data not shown).
We determined the cDNA and genomic nucleotide sequences of TMC2 and Tmc2 by aligning sequences of RT-PCR and RACE products obtained from inner ear, brain and testis tissues. TMC2 and Tmc2 are predicted to encode 101-kD polypeptides whose sequence divergence with TMC1 and Tmc1 occurs mainly in the amino and carboxy termini of the proteins. Comparison of the amino-acid sequences of full-length TMC2 and Tmc2 reveals 83% identity, 57% identity of human TMC1 and TMC2, and 58% identity of mouse Tmc1 and Tmc2 (Fig. 3) 17 .
TMC1 mutations in DFNA36 and DFNB7/B11 deafness
Nucleotide-sequence analysis of TMC1 genomic DNA from affected members of family LMG128 (Fig. 1a) identified a 1714G→A transition predicted to result in a substitution of asparagine for aspartic acid at amino-acid position 572 (Fig. 4a ). This aspartic acid is conserved in TMC1, Tmc1, TMC2 and Tmc2. Sequence analysis of 283 ethnically matched control DNA samples, 68 control samples from a panethnic human diversity panel, and 100 samples from a Caucasian diversity panel revealed that 0 of 902 chromosomes contained this substitution.
Pathogenic TMC1 mutations were identified in ten DFNB7/B11 families, including two nonsense mutations, 100C→T (R34X) and 1534C→T (R512X), 295delA which results in a frameshift and premature termination, and a point mutation 1960A→G predicted to substitute valine for a conserved methionine at position 654 (Fig. 4e) . We identified 100C→T (R34X) in five different families from Pakistan. Comparison of the linked haplotypes at D9S1124, D9S1837 and D9S1876 in these families with those in Pakistani individuals with normal hearing (controls) confirmed a specific association of R34X with a single identical haplotype of these markers (data not shown). The R34X mutation in these apparently unrelated families was probably derived from a common founder, although it is possible that it is a recurrent mutation on this haplotype.
Exons 4 and 5 could not be amplified from affected members of family PKDF22. Sequence analysis of genomic DNA amplified with more distant flanking primers revealed a homozygous genomic 26.7-kb deletion of exons 4 and 5 (IVS3_IVS5del27kb) in deaf PKDF22 family members (Fig. 4f ). Other mutations of TMC1 included an IVS13+1G→A transition in a splice donor site in family PKSR1a (Fig. 4g ). These two mutations, together with the other four mutations, thus accounted for deafness in 10 of the 11 DFNB7/B11 families. The eleventh DFNB7/B11 family, PKSR25, segregated an IVS10-8T→A transversion in a spliceacceptor site (Fig. 4h) ; however, the pathogenic effect of this change is unknown.
Analyses of TMC1 sequence in remaining family members confirmed complete penetrance and co-segregation of these mutations with DFNB7/B11-linked deafness in all of the families. We did not detect any of the DFNB7/B11 mutations in ethnically matched (Pakistani or Indian), normal-hearing control 
Mouse deafness is a recessive allele of Tmc1
We previously proposed the recessive deafness (dn) locus on mouse chromosome 19 as a candidate model for recessive DFNB7 deafness in humans 12 . The integrated genetic and physical maps of this region confirmed that Tmc1 lies within the dn critical interval 18 . PCR analysis of Tmc1 failed to amplify any products from dn/dn genomic DNA with primers flanking exons 13 or 14. Amplification and sequence analysis of all other Tmc1 exons revealed no differences between dn/dn and parental strain DNA. The pattern and sizes of products obtained with nested primer pairs were consistent with a 1.6-kb deletion in dn genomic DNA (data not shown). Sequence analysis of these amplification products identified a 1,656-bp deletion encompassing the 171-bp exon 14 and the adjacent regions of introns 13 and 14 ( Fig. 5) , including the reverse-priming site for amplification of exon 13. This result was confirmed by Southern-blot analysis (data not shown). The splice sites for exons 13 and 15 are not deleted, and nucleotide sequence analysis of Tmc1 dn cDNA confirmed that IVS13_IVS14del1.6kb causes an in-frame deletion of exon 14 from Tmc1 mRNA. Nucleotide sequence analysis of cDNA fragments spanning the rest of the full-length Tmc1 dn mRNA detected no other differences from wildtype Tmc1. Real-time quantitative RT-PCR analysis of RNA from brain and testis revealed approximately similar Tmc1 mRNA levels in Tmc1 dn/dn and Tmc1 ct/ct control mice (data not shown). IVS13_IVS14del1.6kb was not observed in DNA from the parental strain or 13 other diverse mouse strains, providing additional evidence of the pathogenic role of this mutation in deafness mice.
Predicted structural motifs of TMC1
Using BLAST and PROSITE analyses of TMC1, we found no significant sequence similarities to characterized genes or motifs that might provide insight into the putative function of TMC1.
TMHMM2.0 analysis predicted six transmembrane domains with a cytoplasmic orientation of the N and C termini 19 . These regions predicted by TMHMM2.0 correspond to those predicted by TMpred to have the highest probability of being transmembrane helices; TMHMM2.0 has been reported to be more sensitive and specific for detection of transmembrane regions 19 . Analysis of TMC1 and Tmc1 with the SignalP v. 2.0 algorithm detected no signal-peptide sequences 20 .
The N termini of TMC1 and Tmc1 are predicted to have a high proportion of charged amino-acid residues (66/99 and 59/93, respectively) that are grouped together in alternating clusters of approximately 9-12 residues of identical charge (Fig. 3) . The next 80 amino acids have a lower, but significant, proportion of charged side chains (29/80), and the C terminus also has numerous positively charged side chains. These regions of TMC1 and Tmc1 have no detectable sequence similarity to known proteins or structural motifs.
Tissue-specific expression of TMC and Tmc mRNA RT-PCR analyses detected TMC1, Tmc1, TMC2 and Tmc2 mRNA transcripts in human fetal cochlea and inner-ear tissue of postnatal mouse. Northern-blot analysis with a cDNA probe for the 3′ UTR of TMC1 revealed weak hybridization to RNA from human placenta and testis but not other tissues. A northern blot of RNA from a variety of mouse tissues probed with the 3′ UTR of Tmc1 confirmed hybridization to an RNA species of approximately Fig. 5 Intragenic deletion of exon 14 of Tmc1 in deafness (dn) mice. Schematic illustration of the genomic structure of Tmc1 and the IVS13_IVS14del1.6kb mutation in dn mice, with nucleotide sequences for deafness and wildtype parental strain (ct) mice across the IVS13_IVS14del1.6kb breakpoints. 2.5-3 kb in testis RNA, whereas no hybridization was observed on the same blot probed with the 3′ UTR of Tmc2 (data not shown). We assayed the developmental levels of Tmc1 and Tmc2 mRNA expression with TaqMan probes by real-time quantitative RT-PCR of total temporal bone RNA from E14, E18, P1, P5, P10 and P20 C57BL/6J control mice. Comparison to levels of internal control Gapdh mRNA revealed low, constant levels of Tmc1 and Tmc2 mRNA at E14, E18, and P1, which increase by 8-16-fold at P5, P10 and P20 (Fig. 6) . We observed similar mRNA levels for Pres and Myo15a, two other genes expressed specifically in hair cells of the postnatal mouse cochlea [21] [22] [23] .
We further analyzed Tmc1 mRNA expression in postnatal (P5) C57BL/6J mouse inner ears. Figure 6b -e shows a representative result of three analyses in which the antisense probe (Fig. 6b,d ) specifically hybridized to inner and outer hair cells of the cochlea as well as to neurosensory epithelia of the vestibular end organs (data not shown).
Discussion
TMC1 mutations cause hearing loss. The identification of multiple mutations distributed along the entire length of TMC1 provides evidence of its causative role in deafness. The DFNA36 missense mutation D572N probably acts through a dominantnegative or a gain-of-function mechanism, as at least some of the recessive DFNB7/B11 mutations seem to be functional null alleles yet do not cause hearing loss in heterozygous carriers. The pathogenic nature of IVS13_IVS14del1.6kb in dn mice is indicated by the presence of exon 14 in all of the wildtype Tmc1 cDNA sequences that were cloned (data not shown). Although a previously reported inversion on chromosome 19 (ref. 24 ) may be a benign rearrangement in linkage dysequilibrium with dn, we cannot exclude an additional effect of this inversion upon expression of Tmc1 in the inner ear or upon expression of other genes on chromosome 19. In addition, the mouse mutation Beethoven (Bth) on chromosome 19 is a missense mutation of a conserved methionine residue (M412) of Tmc1 (Fig. 3) 25 , indicating that dominant and recessive mutations of TMC1 can cause progressive postlingual hearing loss and profound prelingual deafness, respectively, in both humans and mice.
A model of six membrane-spanning regions and cytoplasmic N and C termini predicted by TMHMM2.0 indicates that the D572N and Bth (M412K) mutations occur in cytoplasmic and extracellular loops, respectively, whereas the recessive missense mutation M654V segregating in family IN-M17 is located in a predicted transmembrane domain. This predicted model of TMC1 membrane topology is similar to those observed in ion channels or transporters, especially the superfamily of multimeric cation channels with six transmembrane segments 26 . M654V may act as a functional null allele by disrupting folding, trafficking, or assembly of its mutant allele products into multimers, whereas D572N and M412K polypeptides may normally fold and assemble with wildtype allele products to exert a dominant negative effect upon the activity of the resulting complex. Tmc1 dn encodes a potential translation product with 57 amino acids deleted from the second cytoplasmic loop predicted by TMHMM2.0 and thus may not necessarily comprise a functional null allele. Differences in otoacoustic emissions among normal-hearing heterozygous Tmc1 dn/+ mice 1 and wildtype controls 27 might reflect a slight dominant effect of Tmc1 dn . Functional analyses of TMC1 mutant allele products and identification of additional mutations may test this model.
Mutations in TMC1 at the DFNB7/B11 locus are a common cause of nonsyndromic recessive deafness in Pakistan and India, where they account for the deafness phenotype in 5.4 ± 3.0% (95% c.i.) of the 230 families that we screened from these areas. The identification of TMC1 mutations in at least 10 of 11 families segregating deafness linked to this locus on chromosome 9q13-21 suggests that locus heterogeneity is unlikely. The mutations detected in these ten families included nonsense, genomic deletion, splice-site and frameshift mutations that would clearly disrupt the expression or function of TMC1. The observed splice acceptor-site substitution in the eleventh family (PKSR25) may be a benign polymorphism in linkage disequilibrium with a mutation in another gene or in a regulatory region of TMC1, although this substitution was not observed in 332 control chromosomes. Analyses of nonsyndromic deafness probands from additional ethnic groups should define the contribution of TMC1 mutations to nonsydromic hearing loss at the DFNA36 and DFNB7/B11 loci in other populations.
The mutant TMC1/Tmc1 phenotypes of DFNA36, DFNB7/B11 (ref. 12) , dn (ref. 28) and Bth (ref. 25) do not seem to be associated with abnormal vestibular phenotypes, although Tmc1 mRNA is expressed in the vestibular neuroepithelium. Normal vestibular function has been reported for some recessive deafness phenotypes caused by mutations in genes expressed in both vestibular and auditory end organs 9, 11 . The lack of detectable vestibular dysfunction associated with TMC1 or Tmc1 mutant phenotypes may reflect basic physiologic differences among the vestibular and auditory systems or functional redundancy with other genes (such as TMC2/Tmc2) in the vestibular system. TMC2 and Tmc2 as candidate genes for auditory phenotypic loci. The identification of TMC2 and Tmc2 mRNA transcripts in the inner ear suggests that they may also be crucial for normal auditory function. The functional relationship between TMC1 and TMC2 in the auditory and vestibular systems is unknown, but may be elucidated by immunolocalization studies and phenotypic analyses of mouse strains segregating mutant alleles of these genes (such as Bth). Although there are no reports of hearing loss loci that co-localize with TMC2 on human chromosome 20p13, there is an auditory phenotypic candidate locus for Tmc2 in the region of conserved linkage on mouse chromosome 2. Tailchaser (Tlc) is an ENU-induced dominant mutation causing progressive hearing loss and vestibular dysfunction 29 . It is possible that mutations in other TMC/Tmc gene family members may also underlie hereditary disorders of balance or hearing.
TMC1 and Tmc1 predicted protein structures. The identification of in-frame stop codons in the 5′ UTRs of TMC1 and Tmc1 indicate that the full-length ORFs have indeed been cloned. The sequences adjacent to the first methionine (M1) codons are predicted to be adequate for translation initiation 15 . The next inframe methionine codon (M113, TMC1) is downstream of the R34X, 295delA, and genomic-deletion (exons 4 and 5) mutations, indicating that either M1 is used for translation initiation or these three mutations disrupt mRNA processing, stability or translation efficiency.
The N-and C-terminal regions of TMC1 have a high proportion of charged residues. Sequences with low complexity that are enriched in arginine, lysine, glutamatic acid and proline residues are observed in protein structures with intrinsic disorder 30 , indicating that these regions of TMC1 are unlikely to be tightly folded into a single, stable conformation. The distinct clusters of alternating opposite charge in the N terminus suggest a model in which electrostatic interactions mediate the reversible association of adjacent clusters into a structure resembling an accordion or spring. Alternatively, these interactions may mediate the association of the entire domain with a similar domain on another polypeptide (such as TMC1). Testing these models and others will be facilitated by correlation with the function and location of TMC1 in cochlear hair cells.
Possible function of TMC1 in hair cells. Homozygous dn mice are profoundly deaf and never show any measurable electrophysiologic responses to auditory stimuli, although endocochlear potentials are intact 1 and stereocilia may initially appear normal 2 . In contrast to other deaf mouse mutants that either don't develop normal hair cells or stereocilia, or at least show some response to auditory stimuli, the lack of auditory responses in dn mice implies a physiologic, not structural, defect of dn hair cells. Although subtle ultrastructural abnormalities have been reported for newborn Tmc1 dn/dn hair cells 31 , the most significant histologic change is degeneration of inner and outer hair cells in the postnatal period 2 . This is consistent with the observed expression of Tmc1 mRNA in postnatal inner and outer hair cells (Fig. 6) . The relative sparing of outer-hair cell stereocilia degeneration in Tmc1 Bth/Bth mice 25 does not reflect a lack of Tmc1 expression in outer hair cells, but may reflect differences in expression of a gene whose product interacts with Tmc1 Bth .
The distinct auditory phenotypes associated with the dn and Bth alleles of Tmc1 (ref. 25) , the specific expression of Tmc1 mRNA in hair cells, the increase of Tmc1 mRNA levels prior to the onset of auditory function at P12 (Fig. 6 ) and the prediction of six transmembrane domains indicate that TMC1 encodes a transmembrane protein that is required for the normal function of cochlear hair cells. It is possible that TMC1, TMC2 or other related proteins mediate an ion-transport or channel function in hair cells, such as the extensively studied mechanotransduction channel activity 32 whose molecular identity remains unknown 5 . We anticipate that determining the in vivo functions of TMC genes may be difficult, but will be facilitated by immunolocalization and electrophysiology studies and characterization of mice segregating mutant alleles of these genes.
Methods
Ascertainment of human subjects. We obtained approval for this study from institutional review boards (IRBs) at the National Institutes of Health (NINDS/NIDCD joint IRB), Center of Excellence in Molecular Biology (Lahore, Pakistan), All-India Institute of Medical Sciences (Delhi) and the Joint Baycrest Centre/University of Toronto IRB. We obtained informed consent from all study subjects. Consanguineous families segregating autosomal recessive, severe-to-profound, prelingual deafness were ascertained in Pakistan and India. A medical history interview and physical examination of members of the North American LMG128 family were performed by an otolaryngologist (A.J.G.). The ethnicity of LMG128 is unspecified owing to privacy concerns. We assessed vestibular function through a motor developmental history interview and tandem gait and Romberg testing. We carried out pure-tone air conduction audiometry under quiet ambient-noise conditions.
Genotype and linkage analysis. We carried out genomic DNA preparations and genotype analyses as described 9 . Samples from affected individuals of Indian and Pakistani families with three or more affected individuals were screened for homozygosity for markers linked to known DFNB loci, and linkage calculations for DFNB7/B11 families were carried out as described 9 . We carried out linkage analysis of the DFNA36 family LMG128 essentially as described 9 , but with the phenotype set as autosomal dominant with penetrance equal to 0.99, disease-allele frequency of 0.0001, equal marker allele frequencies of 0.1, and a phenocopy rate of 1/1,000.
RACE-ready inner-ear cDNA libraries. We used the Micro-Fast Track Kit (Invitrogen) to isolate poly(A+) RNA from human fetal cochleae at 17.5-23 wk or BALB/c mouse cochleae at 14 d. We prepared cochlear RACE-ready cDNA with the Marathon cDNA Amplification Kit (Clontech). RACE-ready cDNA libraries derived from E17 mouse embryo, mouse fetal brain, human brain, human fetal brain and human placenta were purchased from Clontech.
RT-PCR and RACE analyses: TMC1. We used genomic TMC1 sequence to design primers HcDNAF#15 and HcDNAR#11 for PCR amplification of TMC1 from human inner-ear, fetal brain and placenta cDNA libraries. Amplifications were carried out in 50-µl reaction volumes with cDNA Advantage Polymerase (Clontech) and cycling conditions recommended by the manufacturer. We used the sequence of the 0.8-kb product to design primers H5RACE#1 and H5RACE#2 for 5′ RACE of RACE-ready human placenta cDNA (Clontech). Upstream primers H5RACE#3 and H5RACE#4 were thus designed for a second round of 5′ RACE. GENSCAN analysis of human genomic DNA and comparison to the 3′ UTR of mouse Tmc1 was used to identify exon 24 encoding the 3′ end of TMC1. We used reverse primer Hnp2/3′R2, corresponding to the predicted 3′ UTR, and forward primer 3UTR#3 to amplify the 3′ end of TMC1 from the human placenta cDNA library. cDNA encoding the entire TMC1 ORF was amplified and sequenced from the human placental cDNA library using primers HcDNAF#9 and HcDNAR#18. Primer sequences are available from the corresponding author upon request.
RT-PCR and RACE analyses: Tmc1. EST database queries for sequence similarity to TMC1 identified mouse IMAGE cDNA clone 602169, which was purchased from Research Genetics. The sequence analysis of IMAGE:602169 was confirmed and completed in order to design 5′-RACE primers M5RACE#1 and M5RACE#2 and 3′-RACE primers M3RACE#1 and M3RACE#2. RACE substrates were RACE-ready cDNA libraries derived from mouse cochlea, fetal brain and E17 whole embryos. We amplified and sequenced the complete Tmc1 ORF with primers McD-NAF#4 and McDNAR#13 from a mouse organ of Corti cell line, UB/OC-1 (ref. 33 ) and E17 mouse embryo RACE-ready cDNA.
RT-PCR and RACE analyses: TMC2 and Tmc2. We used conserved sequences among TMC1, Tmc1 and potential exons of TMC2 and Tmc2 to design PCR primers TDC2-7F and TDC2-8R for amplification and sequencing of a 187-bp Tmc2 cDNA (spanning two exons) from the mouse inner-ear cDNA library. We used the resulting sequence to design a first set of primers for sequential 5′-and 3′-RACE analyses of the mouse testis cDNA library. We used the RACE product sequences to design primer sets Tdc2-F2/Tdc2-7RR and Tdc2-7L/Tdc2-R2 for PCR amplification of two overlapping cDNA fragments spanning the complete Tmc2 ORF. Sequence conservation among Tmc2 and human genomic sequence was used to design primer sets TDC2-F2/TDC2-5R and TDC2-4L/TDC2-R2 for amplification of two overlapping TMC2 cDNA fragments from a human brain cDNA library.
TMC1 and Tmc1 mutation analyses. We determined the genomic structures of TMC1 and Tmc1 by alignment of cDNA sequences with highthroughput genome sequence (htgs) data, as well as TMC1 genomic sequence from the Celera Publication site 34 and Tmc1 genomic sequence data generated through the use of the Celera Discovery System and Celera's associated databases. We amplified TMC1 exons from genomic DNA and sequenced them as previously described with intronic primers flanking TMC1 exons 9 . We obtained panethnic and Caucasian diversity panels of DNA samples from the NIGMS Human Genetic Cell Repository (Coriell Cell Repositories). We amplified and sequenced Tmc1 exons with flanking intronic primers. Control samples included parental curly-tail (ct/ct) strain DNA and 129/J, AKR/J, BALB/cJ, C3H/HeJ, C57BL/6J, C58/J, CBA/J, CE/J, DBA/2J, P/J, RF/J, SEA/GnJ and SWR/J DNA samples that were purchased from The Jackson Laboratories. We identified the IVS13_IVS14del1.6kb mutation by PCR amplification and sequencing of dn genomic DNA with primers Ex14F and IVS14-1R. We determined the deletion breakpoint sites in wildtype genomic DNA by amplification and sequencing with primers KF and Ex14R for the upstream breakpoint site and primers IVS14-1L and IVS14-1R for the downstream breakpoint site.
Real-time quantitative RT-PCR. We dissected temporal bones from C57BL/6J mice at E14, E18, P1, P5, P10 and P20. We prepared total RNA from each time point from 12 pooled temporal bones in cell lysis buffer (RNeasy Mini Kit, Qiagen), using an FP120 FastPrep Cell Disruptor (Bio101) at 6.5 m s -1 for 45 s. RNA was reverse-transcribed with the SuperScript Preamplification System for First Strand cDNA Synthesis (Life Technology). We carried out real-time PCR with TaqMan Universal PCR master mix and an ABI Prism 7700 (both from Applied Biosystems). We designed primers and probes with Primer Express v. 1.0 (Applied Biosystems). We obtained TaqMan probes and GAPDH control primers from Applied Biosystems (Taqman Rodent GAPDH Control Reagents, VIC Probe).
In situ hybridization analyses. We subcloned cDNA encoding the 3′ UTR of Tmc1 (nt 2466-2895) into pGEM-T Easy (Promega) and confirmed cDNA insert orientations by sequence analysis. The Tmc1 probe has no sequence similarity with Tmc2 or any other sequences in publicly available databases. We generated cRNA probes with T7 RNA polymerase in the presence of [α-35 S]UTP. We processed C57BL/6J mouse temporal bones essentially as described 35, 36 . Sagittally dissected hemi-heads from P5 mice were fixed overnight in PBS / 4% paraformaldehyde and mounted in paraffin. Radiolabeled cRNA probes were hybridized with 10-µm transverse sections and detected by autoradiography.
GenBank accession numbers. Human TMC1 cDNA, AF417578; mouse Tmc1 cDNA, AF417579; human TMC2 cDNA, AF417580; mouse Tmc2 cDNA, AF417581.
